WILLIAMS COS INC (WMB)

US9694571004 - Common Stock

29.82  +0.71 (+2.44%)


Fundamental Rating

3

Taking everything into account, WMB scores 3 out of 10 in our fundamental rating. WMB was compared to 375 industry peers in the Oil, Gas & Consumable Fuels industry. WMB has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, WMB is valued expensive at the moment.




Profitability

Profitability Rating

2

WMB has a good Piotroski-F score of 7.00. This indicates a good health and good profitability for WMB.
WMB has a Return On Assets of 5.30%. This is below the industry average of 13.85%.

WMB's Return On Equity of 22.00% is worse than the rest of the industry. The industry average Return On Equity is 29.81%.
WMB's Profit Margin of 22.50% is worse than the rest of the industry. The industry average Profit Margin is 28.94%.
VS Industry

ROA (5.3%) VS Industry: 21% outperformed.

0.14
2,236.96

ROE (22%) VS Industry: 36% outperformed.

0.15
22,783.17

Profit Margin (22.5%) VS Industry: 40% outperformed.

0.19
294.23

Valuation

Valuation Rating

3

The low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The Price/Earnings Ratio is 14.00, which indicates a correct valuation of WMB.
With a Forward Price/Earnings Ratio of 16.67, WMB is valued correctly.
When comparing the current price to the book value of WMB, we can conclude it is valued correctly. It is trading at 3.08 times its book value.

Compared to an average industry Price/Earning Ratio of 5.32, WMB is valued more expensive than its industry peers. On top of this 86% of the companies listed in the same industry are cheaper than WMB!
Compared to an average industry price book ratio of 1.36, WMB is valued more expensive than its industry peers. 83% of the companies listed in the same industry are valued cheaper.
Compared to an average industry Enterprise Value to EBITDA ratio of 3.53, WMB is valued more expensive than its industry peers. 87% of the companies listed in the same industry are valued cheaper.
VS Industry

Price/Earnings (14) VS Industry: 14% outperformed.

150.25
0.01

Price/Book (3.08) VS Industry: 17% outperformed.

4,762.42
0.04

Enterprise Value/ EBITDA (10.32) VS Industry: 13% outperformed.

236.38
0.32

Growth

Growth Rating

4

WMB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 51.06%, which is quite impressive.
WMB shows quite a strong growth in Earnings Per Share. Measured over the last 5 years, the EPS has been growing by 16.77% yearly.
Based on estimates for the next 5 years, WMB will show a small growth in Earnings Per Share. The EPS will grow by 7.75% on average per year.
Looking at the last year, WMB shows a small growth in Revenue. The Revenue has grown by 9.33% in the last year.

Measured over the past 5 years, WMB shows a small growth in Revenue. The Revenue has been growing by 6.43% on average per year.
Based on estimates for the next 5 years, WMB will show a small growth in Revenue. The Revenue will grow by 2.90% on average per year.
When comparing the EPS growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.
The Revenue growth is decreasing: in the next 5 years the growth will be less than in the last years.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS16.77% 22.01% 51.06% -1.11% 0.25% 4.67% 7.75%
Revenue6.43% 10.17% 9.33% -1.07% 1.44% 3.49% 2.9%

Health

Health Rating

1

The Piotroski-F score of WMB is 7.00. This is a strong score and indicates good health and profitability for WMB.
WMB has a Current Ratio of 0.69. This is a bad value and indicates that WMB is not financially healthy enough and could expect problems in meeting its short term obligations.
When comparing the Current Ratio of WMB to the average industry Current Ratio of 1.18, WMB is less able to pay its short term obligations than its industry peers.
A Quick Ratio of 0.63 indicates that WMB may have some problems paying its short term obligations.

When comparing the Quick Ratio of WMB to the average industry Current Ratio of 1.00, WMB is less able to pay its short term obligations than its industry peers.
Compared to an average industry Debt to Equity Ratio of 0.24, WMB is requires more financing than its industry peers. 93% of its industry peers have a better Debt to Equity Ratio.
WMB has an Altman-Z score of 0.66. This is a bad value and indicates that WMB is not financially healthy and even has some risk of bankruptcy.
When comparing the Altman-Z score of WMB to the average industry Altman-Z score of 2.05, WMB is less financially healthy than its industry peers.
VS Industry

Debt/Equity (1.93) VS Industry: 7% outperformed.

13.98
0.00

Quick Ratio (0.63) VS Industry: 23% outperformed.

0.00
186.31

Current Ratio (0.69) VS Industry: 22% outperformed.

0.00
186.31

Altman-Z (0.66) VS Industry: 22% outperformed.

-509,914.51
307.34

Dividend

Dividend Rating

6

WMB has a Yearly Dividend Yield of 6.16%, which is a nice return.
Compared to an average S&P500 Dividend Yield of 2.71, WMB pays a better dividend.
On average, the dividend of WMB grows each year by 6.22%, which is quite nice.
WMB has paid a dividend for at least 10 years, which is a reliable track record.

WMB's Dividend Yield is comparable with the industry average which is at 5.50.
The dividend of WMB is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
80.95% of the earnings are spent on dividend by WMB. This is not a sustainable payout ratio.
VS Industry

Dividend Yield (6.16%) VS Industry: 53% outperformed.

0.32
63.00

WILLIAMS COS INC

NYSE:WMB (6/2/2023, 8:58:08 AM)

29.82

+0.71 (+2.44%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-03 2023-05-03/amc
Earnings (Next)07-31 2023-07-31/bmo
Inst Owners85.53%
Inst Owner Change-6.63%
Ins Owners0.37%
Ins Owner Change26.97%
Market Cap36.33B
Analysts74.07
Price Target37.47 (25.65%)
Dividend
Industry RankSector Rank
Dividend Yield 6.16%
Dividend Growth(5Y)6.22%
DP80.95%
Div Incr Years5
Div Non Decr Years5
Ex-Date06-09 2023-06-09 (0.4475)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)37.93%
Min EPS beat(2)11.89%
Max EPS beat(2)63.97%
EPS beat(4)3
Avg EPS beat(4)18.95%
Min EPS beat(4)-11.45%
Max EPS beat(4)63.97%
Revenue beat(2)1
Avg Revenue beat(2)6.92%
Min Revenue beat(2)-2.2%
Max Revenue beat(2)16.05%
Revenue beat(4)2
Avg Revenue beat(4)3.82%
Min Revenue beat(4)-2.89%
Max Revenue beat(4)16.05%
PT rev (1m)-0.89%
PT rev (3m)-2.58%
EPS NQ rev (1m)-3.72%
EPS NQ rev (3m)-9.84%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.78%
Revenue NQ rev (1m)5.39%
Revenue NQ rev (3m)-6.63%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-9.91%
Valuation
Industry RankSector Rank
PE 14
Fwd PE 16.67
P/S 3.15
P/FCF 13.05
P/OCF 6.83
P/B 3.08
P/tB 8.81
EV/EBITDA 10.32
EPS(TTM)2.13
EY7.14%
EPS(NY)1.79
Fwd EY6%
FCF(TTM)2.28
FCFY7.66%
OCF(TTM)4.37
OCFY14.65%
SpS9.46
BVpS9.67
TBVpS3.39
PEG (NY)N/A
PEG (5Y)0.83
Profitability
Industry RankSector Rank
ROA 5.3%
ROE 22%
ROIC 6.6%
ROICexc 6.67%
ROICexgc 8.06%
OM 32.45%
PM 22.5%
GM 71.96%
ROA(3y)2.63%
ROA(5y)N/A
ROE(3y)10.95%
ROE(5y)N/A
ROIC(3y)5.08%
ROIC(5y)4.67%
ROICexc(3y)5.16%
ROICexc(5y)4.73%
ROICexgc(3y)6.26%
ROICexgc(5y)5.76%
ROICexcg growth 3Y5.63%
ROICexcg growth 5Y10.04%
ROICexc growth 3Y6.59%
ROICexc growth 5Y11.04%
OM growth 3Y-1.76%
OM growth 5Y4.79%
PM growth 3Y21.79%
PM growth 5Y-7.17%
GM growth 3Y-2.91%
GM growth 5Y-0.82%
F-Score7
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 1.93
Debt/FCF 8.77
Debt/EBITDA 4.24
Cap/Depr 125.83%
Profit Quality 107.33%
Current Ratio 0.69
Quick Ratio 0.63
Altman-Z 0.66
F-Score7
WACC8.26%
ROIC/WACC0.98
Cap/Depr(3y)85.14%
Cap/Depr(5y)113.99%
Profit Quality(3y)457.79%
Profit Quality(5y)N/A
Growth
EPS 1Y51.06%
EPS 3Y22.01%
EPS 5Y16.77%
EPS growth Q2Q85.37%
EPS Next Y-1.11%
EPS Next 2Y0.25%
EPS Next 3Y4.67%
EPS Next 5Y7.75%
Revenue growth 1Y9.33%
Revenue growth 3Y10.17%
Revenue growth 5Y6.43%
Revenue growth Q2Q22.07%
Revenue Next Year-1.07%
Revenue Next 2Y1.44%
Revenue Next 3Y3.49%
Revenue Next 5Y2.9%
EBIT growth 1Y46.17%
EBIT growth 3Y8.23%
EBIT growth 5Y11.52%
EBIT Next Year81.43%
EBIT Next 3Y25.31%
EBIT Next 5Y16.49%
FCF growth 1Y16.1%
FCF growth 3Y19.06%
FCF growth 5Y32.05%
OCF growth 1Y46.83%
OCF growth 3Y9.8%
OCF growth 5Y9.62%
Fundamental Stock Screener Links
Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA